These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32553495)

  • 1. Factors affecting the particle size distribution and rheology of brinzolamide ophthalmic suspensions.
    Vo A; Feng X; Patel D; Mohammad A; Kozak D; Choi S; Ashraf M; Xu X
    Int J Pharm; 2020 Aug; 586():119495. PubMed ID: 32553495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro physicochemical characterization and dissolution of brinzolamide ophthalmic suspensions with similar composition.
    Vo A; Feng X; Patel D; Mohammad A; Patel M; Zheng J; Kozak D; Choi S; Ashraf M; Xu X
    Int J Pharm; 2020 Oct; 588():119761. PubMed ID: 32795488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo.
    Tuomela A; Liu P; Puranen J; Rönkkö S; Laaksonen T; Kalesnykas G; Oksala O; Ilkka J; Laru J; Järvinen K; Hirvonen J; Peltonen L
    Int J Pharm; 2014 Jun; 467(1-2):34-41. PubMed ID: 24680962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel ocular delivery of brinzolamide based on gellan gum: in vitro and in vivo evaluation.
    Sun J; Zhou Z
    Drug Des Devel Ther; 2018; 12():383-389. PubMed ID: 29503531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
    Patel PJ; Gajera BY; Dave RH
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and evaluation of a brinzolamide drug-resin in situ thermosensitive gelling system for sustained ophthalmic drug delivery.
    Li J; Liu H; Liu LL; Cai CN; Xin HX; Liu W
    Chem Pharm Bull (Tokyo); 2014; 62(10):1000-8. PubMed ID: 25099146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brinzolamide Dimethyl Sulfoxide In Situ Gelling Ophthalmic Solution: Formulation Optimisation and In Vitro and In Vivo Evaluation.
    Bhalerao H; Koteshwara KB; Chandran S
    AAPS PharmSciTech; 2020 Jan; 21(2):69. PubMed ID: 31950311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and process factors influencing product quality and in vitro performance of ophthalmic ointments.
    Xu X; Al-Ghabeish M; Rahman Z; Krishnaiah YS; Yerlikaya F; Yang Y; Manda P; Hunt RL; Khan MA
    Int J Pharm; 2015 Sep; 493(1-2):412-25. PubMed ID: 26231106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt). Brinzolamide Dose-Response Study Group.
    Silver LH
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S147-53. PubMed ID: 10665517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Investigation of Process Parameters for Small-Volume Aqueous Suspension Production by the Use of Focused Ultrasonication.
    Zulbeari N; Holm R
    AAPS PharmSciTech; 2024 Aug; 25(6):185. PubMed ID: 39138704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension.
    Jansook P; Stefánsson E; Thorsteinsdóttir M; Sigurdsson BB; Kristjánsdóttir SS; Bas JF; Sigurdsson HH; Loftsson T
    Eur J Pharm Biopharm; 2010 Oct; 76(2):208-14. PubMed ID: 20637867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of sodium chloride to facilitate reduction of particle size of dexamethasone during ball milling.
    Apte SP; Cagle M; Bryant R; Weidenbach A; Kulshreshtha AK
    Drug Dev Ind Pharm; 2003 Mar; 29(3):367-73. PubMed ID: 12741618
    [No Abstract]   [Full Text] [Related]  

  • 13. Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: results from two multicenter comfort studies. Brinzolamide Comfort Study Group.
    Silver LH
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S141-5. PubMed ID: 10665516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneal edema in glaucoma patients after the addition of brinzolamide 1% ophthalmic suspension.
    Tanimura H; Minamoto A; Narai A; Hirayama T; Suzuki M; Mishima HK
    Jpn J Ophthalmol; 2005; 49(4):332-3. PubMed ID: 16075340
    [No Abstract]   [Full Text] [Related]  

  • 15. Analyzing ophthalmic suspension particle size distributions using laser diffraction: Placebo background subtraction method.
    Vo A; Feng X; Smith WC; Zhu D; Patel M; Kozak D; Wang Y; Zheng J; Ashraf M; Xu X
    Int J Pharm; 2021 Apr; 598():120401. PubMed ID: 33636327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive therapy with brinzolamide 1% ophthalmic suspension (Azopt) in patients with open-angle glaucoma or ocular hypertension maintained on timolol therapy.
    Shin D
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S163-8. PubMed ID: 10665519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A continuous manufacturing concept for a pharmaceutical oral suspension.
    Bostijn N; Van Renterghem J; Dhondt W; Vervaet C; De Beer T
    Eur J Pharm Sci; 2018 Oct; 123():576-583. PubMed ID: 30102980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Brinzolamide Primary Therapy Study Group.
    Sall K
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S155-62. PubMed ID: 10665518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of high pressure homogenization and stirred bead milling for the production of nano-crystalline suspensions.
    Nakach M; Authelin JR; Perrin MA; Lakkireddy HR
    Int J Pharm; 2018 Aug; 547(1-2):61-71. PubMed ID: 29787896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the suspending properties of two local Opuntia spp. mucilages on paracetamol suspension.
    Gebresamuel N; Gebre-Mariam T
    Pak J Pharm Sci; 2013 Jan; 26(1):23-9. PubMed ID: 23261724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.